Výsledky vyhledávání - "Muñoz Bellido FJ"

Editorial & Opinion

Assessment of sIgE to rLep d 2 for detecting Lepidoglyphus destructor sensitization.

Autor: Martin-Garcia C; Allergy Department, University Hospital of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Murillo-Casas AD; Allergy Service, Fundación Valle de Lili, ICESI University of Cali, Cali, Colombia., Lázaro-Sastre M; Allergy Department, University Hospital of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Estravís M; Red de Enfermedades Inflamatorias (REI), Instituto de Salud Carlos III, Madrid, Spain., Muñoz-Bellido FJ; Allergy Department, University Hospital of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Red de Enfermedades Inflamatorias (REI), Instituto de Salud Carlos III, Madrid, Spain.; Biomedical and Diagnostic Sciences Department, University of Salamanca, Salamanca, Spain., Mazoteras-Martinez E; Allergy Department, University Hospital of Salamanca, Salamanca, Spain., Dávila I; Allergy Department, University Hospital of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Red de Enfermedades Inflamatorias (REI), Instituto de Salud Carlos III, Madrid, Spain.; Biomedical and Diagnostic Sciences Department, University of Salamanca, Salamanca, Spain.

Publikováno v: Allergy [Allergy] 2024 Dec; Vol. 79 (12), pp. 3540-3542. Date of Electronic Publication: 2024 Aug 11.

Zobrazit plný text záznamu

Akademický článek

Ozenoxacin-Induced Contact Dermatitis With Tolerance to Ciprofloxacin.

Autor: Otero-Fernández MN; Complejo Asistencial Universitario de Salamanca, Salamanca, Spain., Laffond-Yges E; Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Departamento de Ciencias Biomédicas y del Diagnóstico, Universidad de Salamanca, Salamanca, Spain.; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0002/0054), Red de Enfermedades Inflamatorias (REI), Instituto de Salud Carlos III, Madrid, Spain., Castillo-Loja RM; Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Cabrera-Núñez A; Complejo Asistencial Universitario de Salamanca, Salamanca, Spain., Mazoteras-Martínez ME; Complejo Asistencial Universitario de Salamanca, Salamanca, Spain., Muñoz-Bellido FJ; Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Departamento de Ciencias Biomédicas y del Diagnóstico, Universidad de Salamanca, Salamanca, Spain.; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0002/0054), Red de Enfermedades Inflamatorias (REI), Instituto de Salud Carlos III, Madrid, Spain., Dávila I; Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Departamento de Ciencias Biomédicas y del Diagnóstico, Universidad de Salamanca, Salamanca, Spain.; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0002/0054), Red de Enfermedades Inflamatorias (REI), Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: Journal of investigational allergology & clinical immunology [J Investig Allergol Clin Immunol] 2024 Nov 13, pp. 0. Date of Electronic Publication: 2024 Nov 13.

Zobrazit plný text záznamu

Akademický článek

Delabeling of allergy to beta-lactam antibiotics in hospitalized patients: a prospective study evaluating cost savings.

Autor: Sobrino-García M; Allergy Service, University Hospital of Salamanca, Salamanca, Castilla y León, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Castilla y León, Spain., Muñoz-Bellido FJ; Allergy Service, University Hospital of Salamanca, Salamanca, Castilla y León, Spain. fjmbellido@saludcastillayleon.es.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Castilla y León, Spain. fjmbellido@saludcastillayleon.es.; Department of Biomedical and Diagnostic Sciences, University of Salamanca, Salamanca, Castilla y León, Spain. fjmbellido@saludcastillayleon.es.; Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain. fjmbellido@saludcastillayleon.es.; Servicio de Alergología, Hospital Universitario de Salamanca, Paseo de La Transición Española, 37007, Salamanca, Spain. fjmbellido@saludcastillayleon.es., Moreno-Rodilla E; Allergy Service, University Hospital of Salamanca, Salamanca, Castilla y León, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Castilla y León, Spain.; Department of Biomedical and Diagnostic Sciences, University of Salamanca, Salamanca, Castilla y León, Spain.; Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain., Martín-Muñoz R; Hospital Pharmacy Service, University Hospital of Salamanca, Salamanca, Castilla y León, Spain., García-Iglesias A; Admission and Clinical Documentation Service, University Hospital of Salamanca, Salamanca, Castilla y León, Spain., Dávila I; Allergy Service, University Hospital of Salamanca, Salamanca, Castilla y León, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Castilla y León, Spain.; Department of Biomedical and Diagnostic Sciences, University of Salamanca, Salamanca, Castilla y León, Spain.; Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain.

Publikováno v: International journal of clinical pharmacy [Int J Clin Pharm] 2024 Oct; Vol. 46 (5), pp. 1067-1075. Date of Electronic Publication: 2024 Apr 20.

Zobrazit plný text záznamu

Editorial & Opinion

Contact Palpebral Dermatitis and Conjunctivitis Due to Delayed Hypersensitivity to Timolol.

Autor: Sobrino M; Department of Allergy, University Hospital of Salamanca, Spain; Institute for Biomedical Research of Salamanca, IBSAL, Spain., Moreno EM; Department of Allergy, University Hospital of Salamanca, Spain emrodilla@usal.es; Institute for Biomedical Research of Salamanca, IBSAL, Spain; Department of Biomedical and Diagnostic Sciences, University of Salamanca, Spain; Asthma, Allergic and Adverse Reactions (ARADyAL) Network for Cooperative Research in Health of Instituto de Salud Carlos III, Hospital Universitario de Salamanca, Spain., Laffond E; Department of Allergy, University Hospital of Salamanca, Spain; Institute for Biomedical Research of Salamanca, IBSAL, Spain; Department of Biomedical and Diagnostic Sciences, University of Salamanca, Spain., Muñoz-Bellido FJ; Department of Allergy, University Hospital of Salamanca, Spain; Institute for Biomedical Research of Salamanca, IBSAL, Spain; Department of Biomedical and Diagnostic Sciences, University of Salamanca, Spain., Gracia-Bara MT; Department of Allergy, University Hospital of Salamanca, Spain; Institute for Biomedical Research of Salamanca, IBSAL, Spain., Martín C; Department of Allergy, University Hospital of Salamanca, Spain., Macías EM; Department of Allergy, University Hospital of Salamanca, Spain; Institute for Biomedical Research of Salamanca, IBSAL, Spain; Department of Biomedical and Diagnostic Sciences, University of Salamanca, Spain., de Arriba S; Department of Allergy, University Hospital of Salamanca, Spain; Institute for Biomedical Research of Salamanca, IBSAL, Spain; Department of Biomedical and Diagnostic Sciences, University of Salamanca, Spain., Gallardo A; Department of Allergy, University Hospital of Salamanca, Spain., Castillo R; Department of Allergy, University Hospital of Salamanca, Spain., Cabrera A; Department of Allergy, University Hospital of Salamanca, Spain., Dávila I; Department of Allergy, University Hospital of Salamanca, Spain; Institute for Biomedical Research of Salamanca, IBSAL, Spain; Department of Biomedical and Diagnostic Sciences, University of Salamanca, Spain; Asthma, Allergic and Adverse Reactions (ARADyAL) Network for Cooperative Research in Health of Instituto de Salud Carlos III, Hospital Universitario de Salamanca, Spain.

Publikováno v: Dermatitis : contact, atopic, occupational, drug [Dermatitis] 2023 Sep-Oct; Vol. 34 (5), pp. 470-471. Date of Electronic Publication: 2023 Jan 02.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání